The BOPPP Trial

The BOPPP Trial

Using non-selective beta-blockers (NSBBs) to prevent complications of liver cirrhosis. Cirrhosis or liver scarring is a big problem in healthcare. In the United Kingdom, 60,000 people are living with cirrhosis. Sadly about 11,000 will die every year because of it....
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.